Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study

<div>Correlation between periprocedural glycemic variability (expressed as MAGE, MAGE-up, and CONGA-4) and postprocedural NGAL variation. CONGA-4: continuous overall net glycemic action at 4 hours; MAGE: mean amplitude glycemic excursions; MAGE-up: mean amplitude glycemic nadir-to-peak excursions.</div>

Journal of Diabetes Research

fig3

Figure 3

Figure 3: Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 

Figure 3 | Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 